HRS has shared an updated guidance on managing Boston Scientific defibrillation leads at risk of experiencing a significant malfunction. The issue, first reported in July 2025, is believed to impact approximately 350,000 leads still being used today. HRS has shared an updated guidance on managing Boston Scientific defibrillation leads at risk of experiencing a significant malfunction. The issue, first reported in July 2025, is believed to impact approximately 350,000 leads still being used today. | | |
|
AF Symposium 2026 in Boston included new data from some of the biggest names in electrophysiology. Johnson & Johnson MedTech, Abbott, Atraverse Medical, Field Medical, Pulse Biosciences, Argá Medtech SA and CardioFocus were just some of the medtech companies at the heart of late-breaking presentations. AF Symposium 2026 in Boston included new data from some of the biggest names in electrophysiology. Johnson & Johnson MedTech, Abbott, Atraverse Medical, Field Medical, Pulse Biosciences, Argá Medtech SA and CardioFocus were just some of the medtech companies at the heart of late-breaking presentations. | | |
|
The FDA has announced seven Class I recalls related to this issue. Customers are urged to destroy the devices immediately instead of returning them to the manufacturer. The FDA has announced seven Class I recalls related to this issue. Customers are urged to destroy the devices immediately instead of returning them to the manufacturer. | | |
|
eMurmer's new Heart AI software was designed to detect both the presence and absence of heart murmurs in digital stethoscope recordings. It can also gather critical hemodynamic data, helping care teams gain a better understanding of the patient's cardiovascular health. eMurmer's new Heart AI software was designed to detect both the presence and absence of heart murmurs in digital stethoscope recordings. It can also gather critical hemodynamic data, helping care teams gain a better understanding of the patient's cardiovascular health. | | |
|
New drug allows patients to self-treat PSVT. About 2 million people in the U.S. have been diagnosed with condition. New drug allows patients to self-treat PSVT. About 2 million people in the U.S. have been diagnosed with condition. | | |
|
The Globe Pulsed Field System, which secured FDA approval in September 2025, features high-density mapping capabilities and a 122-electrode spherical array. The Globe Pulsed Field System, which secured FDA approval in September 2025, features high-density mapping capabilities and a 122-electrode spherical array. | | |
|
This represents the first FDA clearance for Imricor Medical Systems. "It’s an exciting achievement and a date to be noted and remembered," CEO Steve Wedan said in a statement. This represents the first FDA clearance for Imricor Medical Systems. "It’s an exciting achievement and a date to be noted and remembered," CEO Steve Wedan said in a statement. | | |
|
Extravascular ICDs were developed to avoid complications such as vascular injuries, lead fractures and lead infections. Although rare, these issues can cause serious, life-threatening complications for patients. Extravascular ICDs were developed to avoid complications such as vascular injuries, lead fractures and lead infections. Although rare, these issues can cause serious, life-threatening complications for patients. | | |
|
The all-in-one mapping and single-shot PFA catheter was developed with electrophysiologist feedback in mind. The all-in-one mapping and single-shot PFA catheter was developed with electrophysiologist feedback in mind. | | |
|
The TactiFlex Duo Ablation Catheter, Sensor Enabled was designed to switch from PFA to radiofrequency ablation as needed, providing electrophysiologists with options when treating AFib patients. The TactiFlex Duo Ablation Catheter, Sensor Enabled was designed to switch from PFA to radiofrequency ablation as needed, providing electrophysiologists with options when treating AFib patients. | | |
|
The newest addition to the company's Farapulse PFA Platform was specifically approved to perform cavotricuspid isthmus ablation. The newest addition to the company's Farapulse PFA Platform was specifically approved to perform cavotricuspid isthmus ablation. | | |
|
